Syneron Medical higher on Q1 EPS that beat the Street
Shares of Syneron Medical Ltd. (Nasdaq:ELOS) are getting a pop before the opening bell after the developer of elos combined-energy medical aesthetic devices reported first-quarter earnings this morning that trumped the consensus on Wall Street. Revenues edged up 5% in the quarter, as the company reaped the benefits of a more diversified business model, but fell below analysts’ mean estimate.
Shares gained 8%, or $1.25, to $16.48 in pre-market trading. For detailed price information and recent news stories about Syneron Medical, click ELOS.
About the Author
Reporter Jennifer Schonberger is based in SmallCapInvestor.com's Washington, D.C. bureau.
Read More
(click a star)
Enter comment: